Directory
>
Ryan Yamagata
Ryan Yamagata
Executive Director, CMC Biostatistics | Iovance Biotherapeutics, Inc.
Washington, District of Columbia, United States
Ryan Yamagata
Summary
Ryan Yamagata is an accomplished statistician with extensive experience in the biopharmaceutical industry, currently serving as the Executive Director of CMC Biostatistics at Iovance Biotherapeutics. He has a strong background in statistical modeling and data analytics, which he applies to support critical CMC activities and preclinical studies. Ryan's expertise encompasses a wide array of methodologies, including acceptance sampling, analytical method validation, and quality by design, making him a valuable asset in ensuring compliance with FDA and EMA standards. He has a proven track record of leadership, having previously held senior roles at GSK and Medimmune, where he led teams in statistical sciences for vaccine development. Ryan's ability to collaborate effectively with non-statistical teams highlights his excellent interpersonal skills. He is also a published author, contributing to significant research in the field, including advancements in flow cytometry for microbial assessment in vaccine production. His passion for statistical science and commitment to innovation in drug development positions him as a thought leader in his field.
Ryan Yamagata
Work Experience
Executive Director, CMC Biostatistics at
Iovance Biotherapeutics, Inc.
February 2022 - Present
Principal at
Yamagata Consulting
June 2015 - Present
Lead Statistician & US Head CMC Statistical Sciences, Vaccines Technical Research & Development at
GSK
January 2017 - September 2020
Associate Director, Nonclinical Biostatistics at
MedImmune
March 2014 - June 2015
Associate Director, Statistics at
Shire
January 2012 - March 2014
Senior Principal Statistician at
MedImmune
October 2003 - January 2012
Senior Statistician at
Pfizer
April 2001 - September 2003
Ryan Yamagata
Education
January 1998 - January 2001
Frequently Asked Questions about Ryan Yamagata
What is Ryan Yamagata email address?
Ryan Yamagata's primary email address is *************@iovance.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ryan Yamagata work for?
Ryan Yamagata is a Executive Director, CMC Biostatistics at Iovance Biotherapeutics, Inc., a company specializing in Commercial physical research.
Where Ryan Yamagata graduated from?
Ryan Yamagata holds a degree in Statistics from Brigham Young University.
How can I directly contact Ryan Yamagata?
To contact Ryan Yamagata directly, you can use the email address *************@iovance.com. Complete contact information is available upon registration with Muraena.
Who is Ryan Yamagata?
Ryan Yamagata is an accomplished statistician with extensive experience in the biopharmaceutical industry, currently serving as the Executive Director of CMC Biostatistics at Iovance Biotherapeutics. He has a strong background in statistical modeling and data analytics, which he applies to support critical CMC activities and preclinical studies. Ryan's expertise encompasses a wide array of methodologies, including acceptance sampling, analytical method validation, and quality by design, making him a valuable asset in ensuring compliance with FDA and EMA standards. He has a proven track record of leadership, having previously held senior roles at GSK and Medimmune, where he led teams in statistical sciences for vaccine development. Ryan's ability to collaborate effectively with non-statistical teams highlights his excellent interpersonal skills. He is also a published author, contributing to significant research in the field, including advancements in flow cytometry for microbial assessment in vaccine production. His passion for statistical science and commitment to innovation in drug development positions him as a thought leader in his field.
Ryan`s contact details
*************@iovance.com
Colleagues
Executive Director, Clinical Development, Oncology
Vice President, Cell Therapy Account Teams
Senior Vice President, Medical Affairs
Vice President, Research Alliances
Interim CEO and General Counsel
Chief Medical Officer
Executive Director
SVP Head of Digital and Information Technology
Vice President, Regulatory Affairs
VP, Global Commercial Operations